CONMED Corp — Director's Dealing 2013

Mar 6, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2013-03-05

Reporting Person: DANIELS BRUCE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-03-05	Common Stock	M	2000	$25.70	Acquired	4000	Direct
2013-03-05	Common Stock	F	1679	$30.63	Disposed	2321	Direct
2013-03-05	Common Stock	M	500	$16.46	Acquired	2821	Direct
2013-03-05	Common Stock	F	269	$30.63	Disposed	2552	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-03-05	Sars (Stock Appreciation Rights)	$25.70	M	2000	Disposed	2018-05-16	Common Stock (2000)	Direct
2013-03-05	Sars (Stock Appreciation Rights)	$16.46	M	500	Disposed	2019-06-01	Common Stock (500)	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per
share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2007
Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 20% per year over a five year period, with
any unvested RSUs to vest and be delivered upon the Director's termination of service provided the Director has completed
one full year of service since the date of the award.

F2: The stock appreciation rights ("SARs") were granted under the Company's 2007 Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 20% per year over a five year period, with any unvested SARs to vest upon the Director's termination of service provided the Director has completed one full year of service since the date of the award in which case the SARS shall be exercisable at any time prior to the expiration date of the SAR or within one year after the date of such termination, whichever period is shorter.